Director, US Medical Affairs Solid Tumors Strategy

At Genmab, we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.

The Role

The Director of US Medical Affairs Solid Tumors Strategy will report to the Senior Director, US Medical Affairs Solid Tumors Strategy Lead. S/he will provide medical affairs leadership for assigned asset(s)/indications and support for the overall oncology solid tumor portfolio. The individual will lead the development and execution of the US Medical Affairs strategy that is aligned with the company's goals and meets the needs of the US healthcare market through collaboration with US Commercialization, Global Medical Affairs, Clinical Development, Regulatory, and other cross functional teams.

We have a hybrid model that requires being onsite in Princeton, NJ 60% of the time.

Responsibilities

• Responsible for the US Medical Affairs strategic and tactical planning in coordination with the Global Medical Affairs and other cross-functional teams. 

• Represent US Medical Affairs as a disease area expert in both internal and external venues including the US/Global cross-functional teams, clinical development teams, advisory boards, steering committees, professional society meetings, congresses, and local symposia. 

• Lead pre/peri/post launch medical activities for assigned asset(s) entering the US market.

• Collaborate with US Field Medical Affairs to identify, guide and execute disease/indication regional strategies and tactics with appropriate use of resources.

• Work with clinical development, regulatory, commercial, and market access teams to incorporate insights into product strategies and to support product launches and lifecycle management.

• Participate in the evaluation and support of investigator sponsored trials (IST). Oversee the generation of clinical and real-world evidence in the US that supports the value proposition of our therapies. Ensure the effective dissemination of the data generated through publications, presentations, and other communications.

• Provide strategic input and review of congress abstracts, posters, presentation slides, manuscripts, educational materials, advisory board meeting materials, and medical information response documents, etc.

• Build and maintain strong relationships with key US Thought Leaders (TLs), healthcare professionals, and patient advocacy groups to gather insights, drive advocacy, and ensure our therapies meet the needs of patients and healthcare providers in the US.

• Prioritize and monitor US Medical Affairs tactics …